Search research articles
Contact Us
Filters
Showing results (191-200 of 202) with videos related to
Page
of 21
Sort By:
Journal of Medicinal Chemistry
|
May 15, 1992
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design
W J Thompson, P M Fitzgerald, M K Holloway, et al.
Journal of Medicinal Chemistry
|
April 2, 1993
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors
A K Ghosh, W J Thompson, H Y Lee, et al.
Journal of Medicinal Chemistry
|
March 1, 1991
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors
T A Lyle, C M Wiscount, J P Guare, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801)
T A Lyle, C A Magill, S F Britcher, et al.
Journal of Medicinal Chemistry
|
February 1, 1990
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonists
W J Thompson, P S Anderson, S F Britcher, et al.
Journal of Medicinal Chemistry
|
August 6, 1993
Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands
A K Ghosh, W J Thompson, M K Holloway, et al.
Journal of Medicinal Chemistry
|
January 22, 1993
3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors
A K Ghosh, W J Thompson, S P McKee, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site
M K Holloway, J M Wai, T A Halgren, et al.
Cancer Research
|
May 19, 2001
Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis
G A Piazza, W J Thompson, R Pamukcu, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists
J B Nerenberg, J M Erb, W J Thompson, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 202) with videos related to
Sort By:
Page
of 21
Journal of Medicinal Chemistry
|
May 15, 1992
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted design
W J Thompson, P M Fitzgerald, M K Holloway, et al.
Journal of Medicinal Chemistry
|
April 2, 1993
Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors
A K Ghosh, W J Thompson, H Y Lee, et al.
Journal of Medicinal Chemistry
|
March 1, 1991
Benzocycloalkyl amines as novel C-termini for HIV protease inhibitors
T A Lyle, C M Wiscount, J P Guare, et al.
Journal of Medicinal Chemistry
|
March 1, 1990
Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801)
T A Lyle, C A Magill, S F Britcher, et al.
Journal of Medicinal Chemistry
|
February 1, 1990
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonists
W J Thompson, P S Anderson, S F Britcher, et al.
Journal of Medicinal Chemistry
|
August 6, 1993
Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligands
A K Ghosh, W J Thompson, M K Holloway, et al.
Journal of Medicinal Chemistry
|
January 22, 1993
3-Tetrahydrofuran and pyran urethanes as high-affinity P2-ligands for HIV-1 protease inhibitors
A K Ghosh, W J Thompson, S P McKee, et al.
Journal of Medicinal Chemistry
|
January 20, 1995
A priori prediction of activity for HIV-1 protease inhibitors employing energy minimization in the active site
M K Holloway, J M Wai, T A Halgren, et al.
Cancer Research
|
May 19, 2001
Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis
G A Piazza, W J Thompson, R Pamukcu, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 5, 1999
Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists
J B Nerenberg, J M Erb, W J Thompson, et al.
Page
of 21